New literature on interstitial cystitis and relevant subjects
click on the title to jump to the abstract
contemporary management
CONTEMPORARY MANAGEMENT OF THE PAINFUL BLADDER: A SYSTEMATIC REVIEW. Giannantoni A, Bini V, Dmochowski R, Hanno P, Nickel JC, Proietti S, Wyndaele JJ. Eur Urol. 2012 Jan;61(1):29-53. Epub 2011 Sep 9. PMID: 21920661 Free access
A review of data from a wide range of current therapeutic approaches to PBS/IC, quantifying the effect size from randomised controlled trials (RCTs), and determining the efficacy of treatments for PBS/IC. They concluded that limited evidence exists for the few treatments for PBS/IC. The lack of definitive conclusions is due to the great heterogeneity in methods used, assessment of symptoms, duration of treatment, and follow-up in both RCTs and nRCTs.
pharmacological treatment
THE FUTURE OF PHARMACOLOGIC TREATMENT FOR BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS: LESSONS FROM A META-ANALYSIS. Cruz F. Eur Urol. 2012 Jan;61(1):54-5. Epub 2011 Sep 28.PMID: 21975250 Editorial, Free Access
In this editorial, F. Cruz notes that the article by Giannantoni et al provides overwhelming evidence for urgent profound reflection on the direction of study into BPS/IC. He also comments that a fundamental step in the understanding of BPS/IC is agreement on a single, clear definition.
BPIC-SS
THE BLADDER PAIN/INTERSTITIAL CYSTITIS SYMPTOM SCORE: DEVELOPMENT, VALIDATION, AND IDENTIFICATION OF A CUT SCORE. Humphrey L, Arbuckle R, Moldwin R, Nordling J, van de Merwe JP, Meunier J, Crook T, Abraham L. Eur Urol. 2012 Feb;61(2):271-9. Epub 2011 Oct 18. PMID: 22050826
This Bladder Pain/Interstitial Cystitis Symptom Score (BPIC-SS) was developed in response to a felt need for a patient-reported symptom-based instrument for clinical trial eligibility of bladder pain/interstitial cystitis patients. It was concluded that the BPIC-SS is a reliable, valid, and appropriate questionnaire to select bladder pain/interstitial cystitis patients for clinical trials.
hyaluronic acid and chondroitin sulphate
THE ROLE OF SODIUM HYALURONATE AND SODIUM CHONDROITIN SULPHATE IN THE MANAGEMENT OF BLADDER DISEASE. Damiano R, Cicione A. Ther Adv Urol. 2011 Oct;3(5):223-32. PMID: 22046200 Free Access
The aim of this article was to review the current evidence on the clinic applications of GAGs in urology, with particular emphasis on the therapeutic use of hyaluronic acid (HA) and chondroitin sulphate (CS). The major issue in interpreting the available evidence regarding HA-CS is that most of the reported studies are nonrandomized and without a control arm. HA-CS may be considered for further studies, including randomized, controlled trials with adequate power.
relief from pain and urgency
ALKALINIZED LIDOCAINE AND HEPARIN PROVIDE IMMEDIATE RELIEF OF PAIN AND URGENCY IN PATIENTS WITH INTERSTITIAL CYSTITIS. Parsons CL, Zupkas P, Proctor J, Koziol J, Franklin A, Giesing D, Davis E, Lakin CM, Kahn BS, Garner WJ. J Sex Med. 2011 Nov 14. doi: 10.1111/j.1743-6109.2011.02542.x. [Epub ahead of print]. PMID: 22082303
The results of this study indicate that the combination of alkalinized lidocaine and heparin provides up to 12 hours of relief from urgency and pain associated with IC. This combination provides significant immediate relief of symptoms for patients with IC.
global concepts
GLOBAL CONCEPTS OF BLADDER PAIN SYNDROME (INTERSTITIAL CYSTITIS). Nordling J, Fall M, Hanno P. World J Urol. 2011 Nov 5. [Epub ahead of print]. PMID: 22057291
This article reviews current terminology, diagnostic approaches and treatment. The authors conclude that BPS is no longer considered primarily a bladder disease, but rather one of a number of chronic pain syndromes that is distinguished by being manifest through bladder-related symptoms. A distinct subgroup of patients with Hunner's lesion has specific characteristics, and successful treatment of this subgroup is available.
genetic component
BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS IN TWIN SISTERS. Tunitsky E, Barber MD, Jeppson PC, Nutter B, Jelovsek JE, Ridgeway B. J Urol. 2012 Jan;187(1):148-52. Epub 2011 Nov 16. PMID: 22088343
In this study bladder pain syndrome scores within twin pairs were moderately correlated, implying some genetic component. Increasing age, irritable bowel syndrome, frequent headaches, drug allergies, self-reported urinary tract infections and physical abuse were factors associated with higher bladder pain syndrome scores.
quality of life
VALIDATION OF A QUALITY-OF-LIFE SCALE FOR WOMEN WITH BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS. Bogart LM, Suttorp MJ, Elliott MN, Clemens JQ, Berry SH. Qual Life Res. 2011 Dec 7. [Epub ahead of print]. PMID: 22146841
The aim of this study was to validate a disease-specific scale to measure the impact of symptoms of BPS/IC. Participants for the study were drawn from the RAND Interstitial Cystitis Epidemiology (RICE) Study, a telephone probability survey of 146,231 US households. The authors concluded that the RICE BSI-6 shows excellent internal consistency and strong convergent validity and that it can be used to examine the effects of psychosocial and treatment interventions on QoL among women with BPS/IC.
gender specific pelvic pain
GENDER SPECIFIC PELVIC PAIN SEVERITY IN NEUROGENIC CYSTITIS. Rudick CN, Pavlov VI, Chen MC, Klumpp DJ. J Urol. 2011 Dec 16. [Epub ahead of print]. PMID: 22177208
Rudick et al examined the basis of gender specific pelvic pain in a mouse model of neurogenic cystitis that recapitulates features of IC/PBS and in which pelvic pain is mediated by mast cell histamine. Their findings suggest that pelvic pain in mice with murine neurogenic cystitis is mediated by gender specific responsiveness to mast cells while pelvic pain severity is modulated by genetic factors.
sexual trauma
CHILDHOOD SEXUAL TRAUMA IN WOMEN WITH INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME: A CASE CONTROL STUDY. Nickel JC, Tripp DA, Pontari M, Moldwin R, Mayer R, Carr LK, Doggweiler R, Yang CC, Mishra N, Nordling J. Can Urol Assoc J. 2011 Dec;5(6):410-5. doi: 10.5489/cuaj.11110. PMID: 22154637 Free Access
The purpose of this study was to determine and compare the prevalence and impact of childhood traumatic events, with an emphasis on childhood sexual abuse, on patient symptoms, quality of life and other biopsychosocial parameters. None of the findings remained significant in either the IC/BPS or control groups. Early trauma, such as the occurrence of sexual abuse, is associated with some differences in patient adjustment (e.g., pain, quality of life, depression) but this impact appears to be, at most, very modest.
central pain mechanisms
CENTRAL PAIN MECHANISMS IN CHRONIC PAIN STATES - MAYBE IT IS ALL IN THEIR HEAD. Phillips K, Clauw DJ. Best Pract Res Clin Rheumatol. 2011 Apr;25(2):141-54. PMID: 22094191
The authors investigate mechanisms underlying chronic pain which differ from those underlying acute pain. In chronic pain states, central nervous system (CNS) factors appear to play particularly prominent roles. The hallmark of 'centrally driven' pain conditions is a diffuse hyperalgesic state identifiable using experimental sensory testing, and corroborated by functional neuroimaging. The characteristic symptoms of these central pain conditions include multifocal pain, fatigue, insomnia, memory difficulties and a higher rate of co-morbid mood disorders. In contrast to acute and peripheral pain states that are responsive to non-steroidal anti-inflammatory drugs (NSAIDs) and opioids, central pain conditions respond best to CNS neuromodulating agents, such as serotonin-norepinephrine reuptake inhibitors (SNRIs) and anticonvulsants.
management
CONTEMPORARY MANAGEMENT OF THE PAINFUL BLADDER: A SYSTEMATIC REVIEW. Giannantoni A, Bini V, Dmochowski R, Hanno P, Nickel JC, Proietti S, Wyndaele JJ. Eur Urol. 2011 Sep 9. [Epub ahead of print]. PMID: 21920661
Authors critically review and synthesize data from a wide range of current therapeutic approaches to PBS/IC, to quantify the effect size from randomised controlled trials (RCTs), and to reach clinical agreement on the efficacy of treatments for PBS/IC.
They concluded however that limited evidence exists for the few treatments for PBS/IC. The lack of definitive conclusions is due to the great heterogeneity in methods used, assessment of symptoms, duration of treatment, and follow-up in both RCTs and nonRCTs.
core urinary tract symptoms
CORE LOWER URINARY TRACT SYMPTOM SCORE (CLSS) FOR THE ASSESSMENT OF FEMALE LOWER URINARY TRACT SYMPTOMS: A COMPARATIVE STUDY. Fujimura T, Kume H, Tsurumaki Y, Yoshimura Y, Hosoda C, Suzuki M, Fukuhara H, Enomoto Y, Nishimatsu H, Homma Y. Int J Urol. 2011 Sep 23. doi: 10.1111/j.1442-2042.2011.02848.x. [Epub ahead of print]. PMID: 21951201
The authors conclude that the IPSS alone does not fully evaluate female LUTS, with a possible negative impact on QOL.
They suggest that using the CLSS questionnaire would enable a simple and comprehensive assessment of female LUTS.
symptom variability
SYMPTOM PROFILE VARIABILITY OF INTERSTITIAL CYSTITIS/PAINFUL BLADDER SYNDROME BY AGE. Rais-Bahrami S, Friedlander JI, Herati AS, Sadek MA, Ruzimovsky M, Moldwin RM. BJU Int. 2011 Aug 24. doi: 10.1111/j.1464-410X.2011.10481.x. [Epub ahead of print]. PMID: 21883848
Authors conclude that patients with IC/PBS analysed across a wide spectrum of ages at time of diagnosis portrayed a unique symptom profile pattern.
Patients diagnosed at the youngest ages experienced significantly more urinary urgency, frequency, dysuria, dyspareunia and pain in their external genitalia, while older patients had higher rates of nocturia, urinary incontinence and Hunner's ulcer disease.
REPEATED VULVOVAGINAL FUNGAL INFECTIONS CAUSE PERSISTENT PAIN IN A MOUSE MODEL OF VULVODYNIA. Farmer MA, Taylor AM, Bailey L, Tuttle AH, Macintyre LC, Milagrosa ZE, Crissman HP, Bennett GJ, Ribeiro-da-Silva A, Binik YM, Mogil JS. Sci Transl Med. 2011 Sep 21;3(101):101ra91. PMID: 21937756
Data show that fungal infection can cause persistent pain long after its resolution and that recurrent yeast infection replicates important features of human provoked vulvodynia in the mouse.
IC/PBS types
ARE ULCERATIVE AND NONULCERATIVE INTERSTITIAL CYSTITIS/PAINFUL BLADDER SYNDROME 2 DISTINCT DISEASES? A STUDY OF COEXISTING CONDITIONS. Peters KM, Killinger KA, Mounayer MH, Boura JA. Urology. 2011 Jun 22. [Epub ahead of print]. PMID: 21703668
The authors compare comorbid diagnoses/symptoms in women with ulcerative (ULC) and nonulcerative (N-ULC) IC/PBS and controls.
Notable differences in the number of comorbid diagnoses and symptoms were seen between IC/PBS subtypes and controls.
Subtypes should continue to be evaluated individually to ascertain other similarities and differences.
pelvic pain
SAFETY AND EFFECTIVENESS OF AN INTERNAL PELVIC MYOFASCIAL TRIGGER POINT WAND FOR UROLOGIC CHRONIC PELVIC PAIN SYNDROME. Anderson R, Wise D, Sawyer T, Nathanson BH. Clin J Pain. 2011 May 25. [Epub ahead of print]. PMID: 21613956
This open-label pilot study from Stanford evaluated the safety of a personal “wand” that enables patient's self-treatment of internal myofascial trigger points in the pelvic floor and its effect in reducing pelvic muscle tenderness.
Most patients (95.5%) reported the wand as either very or moderately effective in alleviating pain.
AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald MP, Forrest JB, Gordon B, Gray M, Mayer RD, Newman D, Nyberg L Jr, Payne CK, Wesselmann U, Faraday MM. J Urol 2011 Jun;185(6):2162-70. Epub 2011 Apr 16. PMID: 21497847
A summary of the AUA Guideline for the diagnosis and treatment of IC/BPS. According to the panel, IC/BPS is best identified and managed through use of a logical algorithm as is presented in this Guideline. However, the Panel notes that the most effective approach for a particular patient is best determined by the clinician together with the patient. The Panel emphasises that methods of diagnosis and treatment can be expected to change as the evidence base grows in the future and the strategies presented here will require updating.
depression and panic attacks
Depressive disorders and panic attacks in women with bladder pain syndrome/interstitial cystitis: a population-based sample. Watkins KE, Eberhart N, Hilton L, Suttorp MJ, Hepner KA, Clemens JQ, Berry SH. Gen Hosp Psychiatry 2011 Mar-Apr;33(2):143-9. Epub 2011 Feb 18. PMID: 21596207 This paper from the RAND Corporation reports on the population prevalence of probable depressive disorders and current panic attacks in women with BPS/IC symptoms and describes their characteristics and access to care. The authors suggest that clinicians should be alert to complaints of bladder pain in patients seeking treatment for depressive or anxiety disorders and to complaints of emotional or personal problems in patients seeking treatment for painful bladder symptoms.
Bladder pain syndrome. Hanno P, Nordling J, Fall M. Med Clin N Am 2011;95:55-73 - A useful review of diagnosis and treatment in detail.
urgency perception
Perceptions of "urgency" in women with interstitial cystitis/bladder pain syndrome or overactive bladder. Clemens JQ, Bogart LM, Liu K, et al. Neurourol Urodyn 2010 Nov 5. [Epub ahead of print]. PMID: 21058364 A study comparing urgency symptoms in women with interstitial cystitis/bladder pain syndrome (IC/BPS) and overactive bladder (OAB). Urgency symptoms differed in women diagnosed with IC/BPS versus those diagnosed with OAB, but there was significant overlap. This suggests that "urgency" is not a well-defined and commonly understood symptom that can be utilized to clearly discriminate between IC/BPS and OAB. These findings reinforce the clinical observation that it is often challenging to differentiate between these two conditions.
phenazopyridine
Effects of phenazopyridine on rat bladder primary afferent activity, and comparison with lidocaine and acetaminophen. Aizawa N, Wyndaele JJ. Neurourol Urodyn 2010 Nov;29(8):1445-50. PMID: 20976818 This study explored the effect of phenazopyridine on afferent nerve activity by direct measurement of both Aδ- and C-fibers in the rat, and compared the outcome with the effects of lidocaine (a local anesthetic) and of acetaminophen (an analgesic). It concluded that phenazopyridine can directly inhibit the mechanosensitive Aδ-fibers in the normal rat bladder. This finding might explain its clinical effect in conditions of bladder hypersensitivity.
[CLINICAL AND DIAGNOSTIC EVALUATION IN PATIENTS WITH INTERSTITIAL CYSTITIS][Article in Spanish] Flores-Carreras O, González-Ruiz MI, Martínez-Espinoza CJ, Calderón-Lara SA. Ginecol Obstet Mex 2010 May;78(5):275-80. PMID: 20939238
A useful paper in Spanish concluding that urogynaecologists must consider interstitial cystitis when patients show symptoms of bladder irritability and associated pain with bladder filling. The association of haematuria accompanied by long-term irritability and pain associated with the desire of urination suggests this disease.
bladder biopsy
[CONTRIBUTION BLADDER BIOPSY TO THE STUDY OF UROGYNAECOLOGICAL PATIENT][Article in Spanish] Flores-Carreras O, Martínez-Espinoza CJ, González-Ruiz MI, Montes-Casillas YE. Ginecol Obstet Mex 2010 Mar;78(3):187-90. PMID: 20939223 This Spanish study supports the practice of bladder biopsy when lesions other than those from chronic infection are observed in the presence of tumours or suspect lesions.
intravesical hyalurnan
Long-Term Results Of Intravesical Hyaluronan Therapy In Bladder Pain Syndrome/Interstitial Cystitis. Engelhardt PF, Morakis N, Daha LK, et al. Int Urogynecol J Pelvic Floor Dysfunct 2010 Oct 12. [Epub ahead of print]. PMID: 20938644 The study concluded that besides a high rate of acute symptom remission, intravesical hyaluronan also shows long-term efficacy in a considerable number of BPS/IC patients.
bladder symptoms in Sjögren's syndrome
Multifactorial Causes Of Irritating Bladder Symptoms In Patients With Sjögren's Syndrome. Lee KL, Dong CS, Chen MY, Ho CH, Tai HC, Hung SF, Yu HJ. Neurourol Urodyn. 2010 Oct 6. [Epub ahead of print]. PMID: 20928912 Various factors contribute to the irritating bladder symptoms in patients with SS, with DO being predominant. The LUTS developed in patients with SS are not due to any specific single etiology and each patient must be individually carefully evaluated.
Management strategies
Management Strategies for Painful Bladder Syndrome. Lau TC, Bengtson JM. Rev Obstet Gynecol. 2010 Spring;3(2):42-48. PMID: 20842281
- Management of PBS/IC has been a challenge for generations of physicians, owing to a lack of consensus on its definition, an incompletely understood pathophysiology, and numerous available therapies without high-quality evidence to guide their usage.
- This article reviews the most current conception of PBS/IC and data on effective treatments to recommend a management strategy.
Does mast cell density predict the outcome after transurethral resection of Hunner's lesions in patients with type 3C bladder pain syndrome/interstitial cystitis? Rössberger J, Fall M, Gustafsson CK, Peeker R. Scand J Urol Nephrol. 2010 Sep 13. [Epub ahead of print]. PMID: 20836664
- This study aimed to assess mast cell density in the lamina propria for possible correlation with duration of symptom amelioration after transurethral resection of the bladder (TURB).
- It was concluded that mast cell density does not appear to correlate with duration of symptom amelioration after complete transurethral resection of Hunner's lesions, either in the lamina propria or in the urothelium or detrusor.
Gating of sensory information differs in patients with interstitial cystitis/painful bladder syndrome. Kilpatrick LA, Ornitz E, Ibrahimovic H, Hubbard CS, Rodríguez LV, Mayer EA, Naliboff BD. J Urol. 2010 Sep;184(3):958-63. PMID: 20643444
- Compared to healthy controls, female patients with IC/PBS had decreased ability to adequately filter incoming information and perform appropriate sensorimotor gating. These results suggest that a possible mechanism for altered interoceptive information processing in IC/PBS cases may be a general deficit in filtering mechanisms due to altered pre-attentive processing.
Sacral neuromodulations for female lower urinary tract, pelvic floor, and bowel disorders. Wehbe SA, Whitmore K, Ho MH. Curr Opin Obstet Gynecol. 2010 Oct;22(5):414-9. PMID: 20724927
- This review concludes that the major advantage of SNM lies in its potential to treat the bladder, urethral sphincter, anal sphincters, and pelvic floor muscles simultaneously, which might result in better therapeutic effects.
OAB
The Overlap of Interstitial Cystitis/Painful Bladder Syndrome and Overactive Bladder. Chung MK, Butrick CW, Chung CW. JSLS 2010 Apr 21. [Epub ahead of print] PMID: 20412643 - this prospective study evaluated the prevalence of positive potassium sensitivity and cystoscopy in patients with overactive bladder
- it was found that many patients with OAB symptoms but little or no pain have cystoscopic evidence of IC/PBS and a positive potassium test
- this suggests that OAB patients who have (partially) failed anticholinergic treatment may benefit from IC/PBS therapies
prevalence of PBS/IC symptoms in Korea
Prevalence of painful bladder syndrome/interstitial cystitis-like symptoms in women: a population-based study in Korea. Choe JH, Son H, Song YS, et al. World J Urol 2010 Mar 26. [Epub ahead of print]. PMID: 20340026 - this study estimated the prevalence of PBS/IC-like urinary symptoms in adult women in the general population of South Korea - it was concluded that the prevalence of PBS/IC-like urinary symptoms in South Korean women appeared to be lower than in Europe and the USA, and similar to that of Japan
definition of IC/PBS
Development, Validation and Testing of an Epidemiological Case Definition of Interstitial Cystitis/Painful Bladder Syndrome. Berry SH, Bogart LM, Pham C, et al. J Urol 2010 Mar 17. [Epub ahead of print]. PMID: 20303099 - in this RAND Interstitial Cystitis Epidemiology study, a case definition was developed for interstitial cystitis/painful bladder syndrome with known sensitivity and specificity and this definition was compared with other definitions used in epidemiological studies for IC /PBS - it was concluded that no single case definition of interstitial cystitis/painful bladder syndrome provides high sensitivity and high specificity to identify the condition - new definitions have therefore been developed for prevalence studies
amitriptyline
Effect of Amitriptyline on Symptoms in Treatment Naïve Patients With Interstitial Cystitis/Painful Bladder Syndrome. Foster HE Jr, Hanno PM, Nickel JC, et al. J Urol. 2010 Mar 17. [Epub ahead of print]. PMID: 20303115 - it was found that, seen overall, amitriptyline did not show a significant improvement in IC/PBS patients who had received no previous treatments; however, a significantly higher rate of improvement compared to the placebo group was found in the patients who had managed to take at least 50 mg amitriptyline a day.
amitriptyline
Long-term results of amitriptyline treatment for interstitial cystitis. Hertle L, van Ophoven A. Aktuelle Urol 2010;41(S 01):S61-S65. - in this study it was found that long-term use of amitriptyline is feasible, safe and effective as long as care is taken with the dosage to minimise side effects
Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients. Jacobs BL, Smaldone MC, Tyagi V, et al. Can J Urol 2010;17:4989-94
- urinary NGF levels
were statistically significantly elevated in patients with neurogenic overactive bladder and interstitial cystitis/painful bladder syndrome; urinary NGF levels approached significance in nephrolithiasis patients and levels in patients with bladder cancer were in the range as in those with nephrolithiasis
- the results are difficult to interprete due to the small number of persons in each group: non-diseased urinary tracts (n = 13),
neurogenic overactive bladder (NOAB) (n = 13), idiopathic overactive bladder
(OAB) (n = 17), interstitial cystitis/painful bladder syndrome (IC/PBS) (n = 8),
prostate cancer (n = 7), history of prostate cancer status post robot-assisted
laparoscopic prostatectomy (RALP) (n = 6), active bladder cancer (n = 4), and
nephrolithiasis (n = 4)